CurtisRChongMD

Oncology • Stanford, CA

Clinical Fellow in Medicine, Dana-Farber Cancer Institute

Join to view full profile

Dr. Chong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Chong's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
Johns Hopkins University School of MedicineClass of 2008

Certifications & Licensure

CA State Medical License 2016 - 2025
MA State Medical License 2010 - 2024
NY State Medical License 2016 - 2020
NJ State Medical License 2017 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Resolution of metastatic neck nodes associated with a periauricular cutaneous squamous cell carcinoma after intranodal injection of talimogene laherparepvec.
Laura Morris, Yonglu Che, Curtis Chong, Marketa Limova, Sunil Arani Reddy, Anne Lynn S Chang> ;JAAD Case Reports. 2024 Apr 1
Reply to Groeneveld et al.
Curtis R Chong, Bevin Cohen, Mini Kamboj> ;Clinical Infectious Diseases. 2020 Mar 17
74 citations
Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors.
Curtis Robert Chong, Vivian Park, Bevin Cohen, Michael A. Postow, Mini Kamboj> ;Clinical Infectious Diseases. 2020 Jan 2
Reply to authorReply To Author.
Curtis Robert Chong, Bevin Cohen, Mini Kamboj> ;Clinical Infectious Diseases. 2019 Jun 17
61 citations
Identification of existing drugs that effectively target NTRK1- and ROS1-rearrangements in lung cancer
Curtis R. Chong, Magda Bahcall, Marzia Capelletti, T. Kosaka, Dalia Ercan, Taebo Sim, Lynette M. Sholl, Mizuki Nishino, Bruce E. Johnson, Nathanael S. Gray, Pasi A. Jänne> ;Clinical Cancer Research. 2017 Jan 1
Bath.
Curtis R Chong> ;JAMA Oncology. 2017 Oct 1
10 citations
Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis.
Sarah Finney John, Emmanuel Aniemeke, Ngan P. Ha, Curtis R. Chong, Peihua Gu, Jiangbing Zhou, Ying Zhang, Edward A. Graviss, Jun O. Liu, Omonike A. Olaleye> ;Tuberculosis. 2016 Dec 1
105 citations
Anti–PD-1 inhibitor–related pneumonitis in non–small cell lung cancer
Mizuki Nishino, Emily S. Chambers, Curtis R. Chong, Nikhil H. Ramaiya, Stacy W. Gray, J. Paul Marcoux, Hiroto Hatabu, Pasi A. Jänne, F. Stephen Hodi, Mark M. Awad> ;Cancer Immunology Research. 2016 Apr 1
20 citations
Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation.
Hyun Gyu Lee, Hyemi Kim, Eun Jung Kim, Pil Gu Park, Seung Myung Dong, Tae Hyun Choi, Hyunki Kim, Curtis R. Chong, Jun O. Liu, Jianmeng Chen, Richard F. Ambinder, S. Di...> ;Oncotarget. 2015 Sep 4
67 citations
Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors
Curtis R. Chong, Lori J. Wirth, Mizuki Nishino, Aileen B. Chen, Lynette M. Sholl, Matthew H. Kulke, Ciaran McNamee, Pasi A. Jänne, Bruce E. Johnson> ;Lung Cancer. 2014 Nov 1
738 citations
The quest to overcome resistance to EGFR-targeted therapies in cancer
Curtis R. Chong, Pasi A. Jänne> ;Nature Medicine. 2013 Nov 1
14 citations
Substituted oxines inhibit endothelial cell proliferation and angiogenesis
Shridhar Bhat, Joong Sup Shim, Feiran Zhang, Curtis R. Chong, Jun O. Liu> ;Organic & Biomolecular Chemistry. 2012 Mar 22
26 citations
Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis.
Omonike A. Olaleye, Tirumalai R. Raghunand, Shridhar Bhat, Curtis R. Chong, Peihua Gu, Jiangbing Zhou, Ying Zhang, William R. Bishai, Jun O. Liu> ;Tuberculosis. 2011 Dec 1
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment.
> ;Cancer Discov. 2012 May 16
121 citations
A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment
Elizabeth A. Platz, Srinivasan Yegnasubramanian, Jun O. Liu, Curtis R. Chong, Joong Sup Shim, Stacey A. Kenfield, Meir J. Stampfer, Walter C. Willett, Edward Giovannuc...> ;Cancer Discovery. 2011 Jun 1
78 citations
Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer
Joong Sup Shim, Yoshiyuki Matsui, Shridhar Bhat, Benjamin A. Nacev, Jing Xu, Hyo-eun C. Bhang, Surajit Dhara, Kee Chung Han, Curtis R. Chong, Martin G. Pomper, Alan So...> ;Journal of the National Cancer Institute. 2010 Dec 15
An Unnecessary Death in Zambia
Curtis R. Chong> ;The American Journal of Medicine. 2010 Jul 1
391 citations
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
James Kim, Jean Y. Tang, Ruoyu Gong, Jynho Kim, John J. Lee, Karl V. Clemons, Curtis R. Chong, Kris S. Chang, Mark Fereshteh, Dale R. Gardner, Tannishtha Reya, Jun O. ...> ;Cancer Cell. 2010 Apr 13
Mysterious metformin.
Curtis R Chong, Bruce A Chabner> ;The Oncologist. 2009 Dec 1
86 citations
Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes.
Yunzhao R. Ren, Fan Pan, Suhel Parvez, Andrea Fleig, Curtis R. Chong, Jing-Jing Xu, Yongjun Dang, Jin-Long Zhang, Hongsi Jiang, Reinhold Penner, Jun O. Liu> ;Plos One. 2008 Dec 23
35 citations
Efficacy of Pyrvinium Pamoate against Cryptosporidium parvum Infection In Vitro and in a Neonatal Mouse Model
Autumn S. Downey, Curtis R. Chong, Thaddeus K. Graczyk, David J. Sullivan> ;Antimicrobial Agents and Chemotherapy. 2008 Sep 1
28 citations
Pyrrolidine Dithiocarbamate and Diethyldithiocarbamate Are Active against Growing and Nongrowing Persister Mycobacterium tuberculosis
Sean T. Byrne, Peihua Gu, Jiangbing Zhou, Steven M. Denkin, Curtis R. Chong, David J. Sullivan, Jun O. Liu, Ying Zhang> ;Antimicrobial Agents and Chemotherapy. 2007 Dec 1
9 citations
Catalysis of zinc transfer by D-penicillamine to secondary chelators.
Curtis R. Chong, David S. Auld> ;Journal of Medicinal Chemistry. 2007 Oct 6
714 citations
New uses for old drugs
Curtis R. Chong, David J. Sullivan> ;Nature. 2007 Aug 9
193 citations
The HBV drug entecavir - effects on HIV-1 replication and resistance.
Moira A. McMahon, Benjamin L. Jilek, Timothy P. Brennan, Lin Shen, Yan Zhou, Megan Wind-Rotolo, Sifei Xing, Shridhar Bhat, Braden R. Hale, Robert Hegarty, Curtis R. Ch...> ;The New England Journal of Medicine. 2007 Jun 21
Join now to see all

Lectures

A phase Ia/Ib, open label, multicenter, dose-escalation study of BI 907828 (MDM2-p53 antagonist) in adult patients with advanced or metastatic solid tumors.
2019 ASCO Annual Meeting - 6/1/2019